0000899243-17-028019.txt : 20171206 0000899243-17-028019.hdr.sgml : 20171206 20171206092211 ACCESSION NUMBER: 0000899243-17-028019 CONFORMED SUBMISSION TYPE: 3 PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20171201 FILED AS OF DATE: 20171206 DATE AS OF CHANGE: 20171206 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: HOFFMAN STEPHEN J CENTRAL INDEX KEY: 0001190418 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 000-53057 FILM NUMBER: 171241273 MAIL ADDRESS: STREET 1: C/O SKYLINE VENTURES STREET 2: 525 UNIVERSITY AVE., SUITE 1350 CITY: PALO ALTO STATE: CA ZIP: 94301 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Aerpio Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001422142 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 611547850 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 9987 CARVER ROAD CITY: CINCINNATI STATE: OH ZIP: 45242 BUSINESS PHONE: (513) 985-1920 MAIL ADDRESS: STREET 1: 9987 CARVER ROAD CITY: CINCINNATI STATE: OH ZIP: 45242 FORMER COMPANY: FORMER CONFORMED NAME: ZETA ACQUISITION CORP II DATE OF NAME CHANGE: 20071227 3 1 doc3.xml FORM 3 SUBMISSION X0206 3 2017-12-01 1 0001422142 Aerpio Pharmaceuticals, Inc. ARPO 0001190418 HOFFMAN STEPHEN J C/O AERPIO PHARMACEUTICALS, INC. 9987 CARVER ROAD, SUITE 420 CINCINNATI OH 25242 0 1 0 0 Chief Executive Officer Exhibit 24.1: Limited Power of Attorney /s/ Stephen Hoffman, M.D., Ph.D. 2017-12-06 EX-24.1 2 attachment1.htm EX-24.1 DOCUMENT
                               POWER OF ATTORNEY

     Know all by these presents, that the undersigned hereby constitutes and
appoints each of Joseph Gardner, Danielle Lauzon, James Xu, Amoli Pandya, and
Brian Fleming, signing singly, the undersigned's true and lawful attorney-in-
fact to:

     (1)   execute for and on behalf of the undersigned, in the undersigned's
           capacity as an officer and/or director of Aerpio Pharmaceuticals,
           Inc. (the "Company"), (i) Form ID, including any attached documents,
           to effect the assignment of codes to the undersigned to be used in
           the transmission of information to the United States Securities and
           Exchange Commission using the EDGAR System, (ii) Forms 3, 4 and 5,
           (iii) Schedule 13D, (iv) Schedule 13G and (v) amendments of each
           thereof, in accordance with Section 16(a) of the Securities Exchange
           Act of 1934, as amended, and the rules thereunder;

     (2)   do and perform any and all acts for and on behalf of the undersigned
           which may be necessary or desirable to complete and execute any such
           Form 3, 4 or 5, Schedule 13D. Schedule 13G or any amendments thereto
           and timely file such form with the United States Securities and
           Exchange Commission and any stock exchange or similar authority; and

     (3)   take any other action of any type whatsoever in connection with the
           foregoing which, in the opinion of such attorney-in-fact, may be of
           benefit to, in the best interest of, or legally required by, the
           undersigned, it being understood that the documents executed by such
           attorney-in-fact on behalf of the undersigned pursuant to this Power
           of Attorney shall be in such form and shall contain such terms and
           conditions as such attorney-in-fact may approve in such attorney-in-
           fact's discretion.

     The undersigned hereby grants to each such attorney-in-fact full power and
authority to do and perform any and every act and thing whatsoever requisite,
necessary, or proper to be done in the exercise of any of the rights and powers
herein granted, as fully to all intents and purposes as the undersigned might or
could do if personally present, with full power of substitution or revocation,
hereby ratifying and confirming all that such attorney-in-fact, or such
attorney-in-fact's substitute or substitutes, shall lawfully do or cause to be
done by virtue of this Power of Attorney and the rights and powers herein
granted. The undersigned acknowledges that the foregoing attorneys-in-fact, in
serving in such capacity at the request of the undersigned, are not assuming,
nor is the Company assuming, any of the undersigned's responsibilities to comply
with Section 16 or Regulation 13D-G of the Securities Exchange Act of 1934, as
amended. The undersigned hereby agrees to indemnify the attorney-in-fact and the
Company from and against any demand, damage, loss, cost or expense arising from
any false or misleading information provided by the undersigned to the attorney-
in-fact.

     This Power of Attorney shall remain in full force and effect until the
           undersigned is no longer required to file Forms 3, 4 and 5 with
           respect to the undersigned's holdings of and transactions in
           securities issued by the Company, unless earlier revoked by the
           undersigned in a signed writing delivered to the foregoing attorneys-
           in-fact.  This Power of Attorney may be filed with the United States
           Securities and Exchange Commission as a confirming statement of the
           authority granted herein. This Power of Attorney supersedes any prior
           power of attorney in connection with the undersigned's capacity as an
           officer and/or director of the Company.  This Power of Attorney shall
           expire as to any individual attorney-in-fact if such attorney-in-fact
           ceases to be an executive officer of the Company.

     IN WITNESS WHEREOF, the undersigned has caused this Power of Attorney to be
executed as of December 1, 2017.


                                       /s/ Stephen Hoffman, M.D., Ph.D.
                                       -------------------------------------
                                       Stephen Hoffman, M.D., Ph.D